Baxter takes over end-stage renal care for Humana:
This article was originally published in Clinica
Baxter International's Renal Management Strategies unit has signed a three-year contract to manage end-stage renal disease patients for managed health care company Humana. Baxter describes it as the first proactive national agreement to enhance the quality of life for such patients through advanced disease management. RMS will begin managing four of 16 targeted markets in the US on October 1, and the remainder by spring 1998.